P J Blackshear

发表

Phosphorylation of Tristetraprolin, a Potential Zinc Finger Transcription Factor, by Mitogen Stimulation in Intact Cells and by Mitogen-activated Protein Kinase in Vitro(*)

M J Thompson, M. Thompson, P. Blackshear, 1995, The Journal of Biological Chemistry.

The NIEHS Xenopus maternal EST project: interim analysis of the first 13,879 ESTs from unfertilized eggs.

P. Blackshear, G. Bouffard, M. Soares, 2001, Gene.

Implantable infusion pumps: clinical applications.

P. Blackshear, P J Blackshear, 1985, Methods in enzymology.

The use of an implantable insulin pump in the treatment of type II diabetes.

H Buchwald, F D Dorman, T D Rohde, 1982, The New England journal of medicine.

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

B. Haynes, P. Blackshear, H. Broxmeyer, 1996, Immunity.

Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis.

H Buchwald, P D Schneider, T D Rohde, 1980, Surgery.

High level, cell-specific expression of ornithine decarboxylase transcripts in rat genitourinary tissues.

D. Stumpo, P. Blackshear, W. Young, 1989, Molecular endocrinology.

Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability.

P. Blackshear, W. Lai, E. Carballo, 2000, Blood.

The design and initial testing of an implantable infusion pump.

H Buchwald, F D Dorman, P. Blackshear, 1972, Surgery, gynecology & obstetrics.

Regulation of rat ornithine decarboxylase mRNA translation by its 5'-untranslated region.

P. Blackshear, P J Blackshear, J M Manzella, 1990, The Journal of biological chemistry.